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ABSTRACT
The Database of Protein Disorder (DisProt, URL:
www.disprot.org) has been significantly updated and
upgraded since its last major renewal in 2007. The
current release holds information on more than 800
entries of IDPs/IDRs, i.e. intrinsically disordered pro-
teins or regions that exist and function without a
well-defined three-dimensional structure. We have
re-curated previous entries to purge DisProt from
conflicting cases, and also upgraded the functional
classification scheme to reflect continuous advance
in the field in the past 10 years or so. We define
IDPs as proteins that are disordered along their en-
tire sequence, i.e. entirely lack structural elements,
and IDRs as regions that are at least five consecu-
tive residues without well-defined structure. We base
our assessment of disorder strictly on experimen-
tal evidence, such as X-ray crystallography and nu-
clear magnetic resonance (primary techniques) and
a broad range of other experimental approaches
(secondary techniques). Confident and ambiguous
annotations are highlighted separately. DisProt 7.0
presents classified knowledge regarding the exper-
imental characterization and functional annotations
of IDPs/IDRs, and is intended to provide an invalu-
able resource for the research community for a better
understanding structural disorder and for developing
better computational tools for studying disordered
proteins.
INTRODUCTION
Our traditional view of protein structure and function is
deeply rooted in the structure–function paradigm which
stated that the polypeptide chain of proteins needs to fold
into a stable three-dimensional (3D) structure, which is
a prerequisite of the functioning of the protein. The ex-
treme explanatory power and success of this model is at-
tested by more than hundred thousand high-resolution
structures in the Protein Data Bank (PDB) (1) and many
Nobel Prizes awarded for describing structures central to
understanding important cell-biological phenomena. It has
been suggested almost 20 years ago, however, that many
proteins or regions of proteins in various proteomes lack
such stable 3D structure, and are rather intrinsically dis-
ordered under native, physiological-like conditions (thus
named IDPs/IDRs, respectively) (2–4). The recognition of
this structural phenomenon brought a radical change in the
structure–function paradigm, and critically extended the
general appreciation of the role of dynamics in protein func-
tion. It has been recognized that structural disorder, which
is prevalent in all organisms, plays roles primarily in cellular
signaling and regulation (5). Because of that, IDPs/IDRs
are often implicated in diseases (6) and represent important
drug targets (7).
The structural and functional characterization of disor-
dered proteins represents a special challenge, because they
exist as an ensemble of rapidly interconverting conforma-
tions. Although they cannot be crystallized and thus can-
not be directly characterized byX-ray crystallography, there
are a variety of techniques that can report on their highly
dynamic structural state at low- or even high spatial and
temporal resolution (3). The current best structural descrip-
tion of IDPs/IDRs is by structural ensembles, which can
be solved by a combination of experimental and computa-
tional approaches and are collected into a dedicated struc-
tural database, PED (8).
Studies of the structure–function relationship of dis-
ordered proteins have shown that in certain cases their
function arises directly from the disordered state (entropic
chains), whereas in many other cases their function em-
anates frommolecular recognition accompanied by induced
folding to specific binding partners, such as another pro-
tein, RNA or DNA molecule (9,10). In these functions, the
sensitivity to regulated remodeling of the disordered struc-
tural ensemble is an excellent substrate for protein regula-
tion, as exemplified by frequent post-translational modifi-
cations (11) and special modes of allosteric regulation (12)
involving IDPs/IDRs.
Due to the prevalence and importance of structural disor-
der, several dedicated databases covering various aspects of
IDPs/IDRs have appeared in the past decade. DisProt is the
primary repository of disorder-related data on sequence-
and functional annotations, focusing on disordered proteins
or regions with experimental verification (13,14). Several
other databases are based on predictions of disorder, such
as D2P2, which contains disorder protein predictions by a
variety of predictors on 1765 complete proteomes (15),Mo-
biDB, which features three levels of annotations, manually
curated, indirect and predicted for all UniProt sequences
(over 80 million) (16), and IDEAL, which contains man-
ual annotations of interaction regions undergoing induced
folding, sites of post-translationalmodifications and assign-
ments of structural domains (17). In addition, as already
mentioned, PED is the database that gathers structural in-
formation on IDPs/IDRs, in the form of structural ensem-
bles (8). The interaction of IDPs/IDRswith their target(s) is
most oftenmediated by short continuous stretches of amino
acids such as Molecular Recognition Elements/Features
(MoREs/MoRFs) (18) and short/eukaryotic linear mo-
tifs (SLiMs/ELMs), which have been collected in the
ELM database (19). Less frequently, partner interactions
of IDPs/IDRs may also be mediated by intrinsically dis-
ordered domains (IDDs), i.e. longer regions that conform
to the definition of domains as functional, evolutionary
and structural units (20). Although probably still underap-
preciated, some of these IDDs may be found in the Pfam
database of protein families which includes their annota-
tions and underlying multiple sequence alignments (21).
DisProt is central to all IDP-related research efforts, be-
cause it collects and presents in a structured way the core
experimental evidence reported for structural disorder in
proteins. To give a new impetus to the field, we have sig-
nificantly updated and upgraded it with new features. This
new release––DisProt 7.0––contains more than 800 entries
of IDPs/IDRs. We have also re-defined and extended func-
tional categories laying the basis for a functional ontology
of IDPs, now encompassing 7 major classes and 35 sub-
classes, all based on published experimental data.
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Detection and characterization of IDPs
Technical advances in the field of biophysical and struc-
tural biology in the last 50 years have provided the scientific
community with an arsenal of techniques to tackle the chal-
lenging characterization of IDPs/IDRs (4,22). The various
methods differ in their extent of sophistication, and hence in
their technical demand, as well as in the nature of the infor-
mation they provide. Nuclear magnetic resonance (NMR)
andX-ray crystallography provide site-specific information,
whereas other methods provide more qualitative and global
information (e.g. far-UV circular dichroism, size-exclusion
chromatography; SEC).
The rise of the field of protein disorder has greatly ben-
efited from structural biology, because structures deposited
in the PDB (1) have been instrumental for the development
of disorder predictors, often trained on regions of missing
electron density. Developments of multidimensional het-
eronuclear NMR also enabled the structural characteriza-
tion of disordered proteins of increasing size (23,24). In par-
ticular, heteronuclear single quantum coherence (HSQC)
experiments are most commonly used to define protein
disorder irrespective of whether residue-specific chemical
shifts are available or not, as crowded HSQC spectra, char-
acterized by a poor spread of resonances, are typical of
IDPs/IDRs. The same feature of low spread of proton res-
onances is also apparent in one-dimensional proton-based
NMRspectra, which offers the obvious advantage of not re-
quiring isotopic labeling. Following assignment of the spec-
trum, quantitative estimations of disorder can be obtained
through various NMR observables, such as chemical shifts,
relaxation rates, residual dipolar couplings and resonance
intensities in paramagnetic relaxation enhancement exper-
iments. These data enable probing sequence-specific struc-
tural information in IDPs/IDRs. A particular strength of
NMR is that it can be increasingly applied under truly in
vivo conditions, in live cells (25). Therefore, these two experi-
mental approaches, X-ray crystallography and multidimen-
sional NMR, are considered as the ‘primary techniques’
providing evidence for structural disorder on a per residue
basis in DisProt.
It should not miss our attention, though, that due to the
expenses of isotopic labeling in NMR and the high rate
of failure in protein crystallization, it would be unreason-
able to only rely on these two approaches to document
protein disorder. Therefore, beyond X-ray crystallography
and NMR, a plethora of alternative biochemical and bio-
physical approaches (termed ‘secondary techniques’) pro-
vide orthogonal information on protein disorder in DisProt
(4,22). The various approaches are of course not equivalent
in terms of reliability, resolution and accuracy and suffer
from specific drawbacks and limitations. Structural disorder
is often based on far-UV CD spectroscopy, which is overall
quite reliable, but does not enable discrimination between
ordered and molten globular forms. Near-UV CD, beyond
being able to unveil the lack of ordered structure, has the
advantage of distinguishing between globular and molten
globule forms. Another hallmark of disorder is anomalous
sodium dodecyl sulphate-polyacrylamide gel electrophore-
sis migration, where IDPs have a high apparent molecular
mass. IDPs/IDRs also behave anomalously in SEC, light
scattering (DLS, MALS), and in small-angle X-ray scat-
tering in that they display hydrodynamic radii (RH) and
radii of gyration (Rg) higher than expected, reflecting an
extended conformation.
Fluorescence spectroscopy is another common method
to assess disorder. Intrinsic fluorescence probing the chem-
ical environment of tryptophan residues provides informa-
tion about their solvent-accessibility, whereas thermal dif-
ferential scanning fluorimetry––similar to differential scan-
ning calorimetry––can highlight the lack of a cooperative
thermal transition and hence absence of ordered structure.
Fluorescence resonance energy transfer between external
fluorophores can even generate information on distance dis-
tributions and help solve the structural ensemble of the IDP
(26). Hyper-sensitivity to proteolysis is also commonly used
to map out disordered regions of proteins. Recently, native
mass spectrometry exploiting nano-electrospray ionization
(27,28) and high-speed atomic force microscopy operating
at the single-molecule level (29) have emerged as attractive
alternatives to address structural disorder.
As a last statement, it is noteworthy that the higher the
number of independent experimental lines supporting dis-
order, the higher the reliability of the annotation. Further-
more, multi-dimensional information may help realize that
structural disorder is not a single homogeneous structural
state along an order-disorder binary classification coordi-
nate, it rather represents a continuumof states from the fully
ordered to the fully disordered. Similarly, many examples of
biological relevant disorder in fragments that are missing
from the full length protein have been reported. Further-
more, numerous functional examples of ‘conditional disor-
der’, i.e. instances where a disordered region functions by
transitions to or from a folded state (30), or when disor-
der is only observed in a fraction of similar structures (31),
lead to ambiguity and clearly points to the need for car-
rying out complementary experiments. In addition, an ex-
treme case leading to conflicting results is represented by
instances where a protein region, predicted to be ordered, is
not defined in the electron density in one crystal structure
while being ordered in another one (for an example see (32)
and DisProt entry DP00133). Do these ambiguous regions
represent a new class of disorder that escape detection us-
ing the currently available disorder predictors (thus setting
the scene for their improvement), or a contrario are they the
result of static disorder that arises from experimental condi-
tions or domain wobbling? Combining information from a
variety of sources may help clarify these cases and also im-
prove meaningful descriptions of IDPs as conformational
ensembles (33,34), which may lead to future descriptions of
the structure–function relationship of IDPs.
Database structure and implementation
Database records. The technology ofDisProt has been up-
dated and is now based on a document-orientedMongoDB
database. Stored documents are of two types, ‘protein’ in-
cluding general information about the protein and ‘disor-
dered region (DR)’ including evidence of disorder from lit-
erature. Protein information is retrieved from UniProt and
includes cleavage sites and chain/peptide boundaries for
polyproteins and processed proteins. DisProt is sequence-
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Figure 1. DisProt sample entry, human p53 protein (DP00086). Several experiments have been carried out to characterize the human p53 protein. DisProt
reports literature evidence for IDRs. In particular, 11 different IDR evidences (Region Evidences) have been collected from nine different papers by two
different curators. Most of these are related to the N-terminus and come from different types of experiments (Disorder Region Details). Disorder regions
and the number of DisProt evidences, separated into confident and ambiguous annotations, can be compared with structural information from the Pfam
and MobiDB databases in the Disorder Overview. DisProt also provides function annotation of IDRs by reporting molecular function, transition and
partner terms (Functional Annotation). A literature reference is provided for each annotated IDR, linked to the relevant PubMed entry.
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centric and different isoforms correspond to different en-
tries as in the previous version. Cleaved proteins are merged
into a single entry as they are products of the same native
sequence. DisProt accession numbers now follow a single
format and all previous entries with a ‘ xxx’ suffix were re-
moved. DR records are evidence-centric, i.e. different docu-
ments are stored for different experiments evenwhen related
to the same region. Forcing a one-to-one paradigm allows
to track annotation evidence type and the corresponding
literature source unambiguously. DR records also include
experimental evidence quality tags for ambiguous annota-
tions. Sometimes experiments are carried out on engineered
sequences or fragments whichmay prove ambiguous to gen-
eralize for the entire sequence (AMBSEQ). Moreover, dis-
order boundaries are occasionally not clear from the liter-
ature (AMBLIT) or experiments are performed under ex-
tremely non-physiological conditions (AMBEXP). Thema-
jor improvement from previous versions is the manually cu-
rated functional annotation of the regions. Whenever pos-
sible, curator-associated functions based on literature evi-
dence are indicated by selecting terms from a new ontol-
ogy built for describing disorder-related functional modes.
If none of the current terms in the new ontology give a
proper description of the functional mode, the curator may
propose a new term to be added to the ontology.Acceptance
of the new term will require approval by the IDP/IDR on-
tology committee.
Annotation pipeline. The newDisProt data have been gen-
erated by a community effort through a web server interface
accessible upon registration. The same infrastructure can be
used both to create and update entries. Curators provide an
annotation through a submission form where all fields are
validated on the client-side and a sequence viewer allows the
comparison of assigned regions with structure information
(Pfam domains, MobiDB disorder). Of note, the name of
the curator is clearly visible in the entry to allow proper at-
tribution of credit. The pipeline is fully automatic and can
be potentially applied to the entire UniProt database. The
DisProt public database is a snapshot of the community an-
notations.
Entry page. The entry page features four different sec-
tions (Figure 1). A protein information table gives the pro-
tein name, gene, synonyms, identifiers, taxonomy and ‘ho-
mologous’ entries inferred from sequence similarity. An in-
teractive feature viewer reports DisProt disorder regions
separated into confident and ambiguous annotations, col-
ored brown for intrinsically disordered regions and purple
for context-dependent regions. Pfam domains along with
PDB and predicted disorder derived fromMobiDB are also
shown. Below, a detailed feature viewer provides different
visualization layers to highlight different functional aspects
(ontology terms) and the strength of available disorder ev-
idence. Each position in the sequence is colored according
to the number and type of evidence. Last but not least, the
full curator-generated list of region evidences is reported on
the bottom of the page and can be filtered by selecting an
element (region) in the feature viewer. Figure 1 shows the
current DisProt annotation for the human p53 protein. The
combination of DisProt and PDB annotation clearly shows
how p53 contains several segments undergoing disorder to
order transitions. Evidence for disorder from the literature
in the central p53 DNA binding domain, for which many
crystal structures are available in the PDB, is ambiguous
and highlighted with AMBLIT. Similar conflicts can prob-
ably be found in scores of DisProt entries and demonstrate
the importance of flagging ambiguous data.
Browsing and searching data. Both browsing and search-
ing functionalities are provided in a single solution from
the ‘Browse’ page. A sortable, customizable and filterable
table lists all entries by protein. Alternatively, another table
listing all regions is available and accessible through the ‘re-
gions’ button. Complex queries can be simulated applying
different filters to different columns. Specific entries can be
selected manually and customized views can be generated
by adding or removing columns. Filtered and/or selected
data can be downloaded both in text and JSON formats.
Alternatively, the ‘Search’ page allows the user to search for
specificwords in a free-text formor to search forDisProt en-
tries similar to a query sequence. Output for either search is
a provided in a simplified form.
Feedback page. DisProt users are highly encouraged to
suggest additional disorder annotations or changes to ex-
isting annotations using the ‘Feedback’ page. This contains
a drop-downmenu guiding the choice of feedback provided
(e.g. website experience, novel annotations) and a message
field. For feedback related to data entries, the user is asked
to provide either theUniProt orDisProt ID and (where pos-
sible) a PubMed reference. All messages are reviewed by the
curators and integrated in the database as time permits.
Web technology. The DisProt server is implemented in
Node.js (https://nodejs.org) using the REST (Representa-
tional State Transfer) architecture. The data can be accessed
through the web interface or programmatically exploit-
ing the RESTful functionality. Please refer to the ‘Help’
section of the website for details on using the DisProt
web services. The web interface is built using Angular.js
(https://angularjs.org) and Bootstrap (http://getbootstrap.
com) frameworks. The feature viewer is implemented on top
of the Bio.js library.
Database content: upgrades and updates
Entries in DisProt 7.0 came from three major sources: (i)
from the previous version of DisProt (where conflicting
cases have been re-annotated), (ii) novel cases identified as
PDB entries with long regions of missing electron density
and (iii) proteins identified by text-mining in PubMed ab-
stracts for keywords ‘intrinsically disordered’, ‘intrinsically
unstructured’ and ‘structural disorder’. New proteins se-
lected based on disorder content (estimated based on Mo-
biDB data) were prioritized (if appropriate information was
available in SwissProt) to concentrate on well-studied and
most interesting cases. New proteins were also selected by
curators themselves to exploit their specific previous knowl-
edge. All entries from previous versions were re-annotated
to remove inconsistencies. One hundred and ninety-eight
previous entries were completely removed and 469 modi-
fied. Recurring problems being fixed were wrong organism
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Table 1. DisProt annotation content
Method/function Proteins Regions Residues
Nuclear magnetic resonance (NMR) 333 592 32 926
X-ray crystallography 326 683 20 742
Circular dichroism (CD) spectroscopy, far-UV 261 352 53 935
Sensitivity to proteolysis 75 95 13 961
Size exclusion/gel filtration chromatography 62 67 12 206
Proton-based NMR 53 69 7723
SDS-PAGE gel, aberrant mobility on 34 34 6326
Other methods 237 273 41 833
Disorder transition 564 1505 151 498
Molecular function 489 1199 106 670
Molecular partner 444 1108 119 665
Distribution of DisProt annotation based on experimental evidence (method) and disorder function (function). As each annotated disorder region corre-
sponds to one piece of experimental evidence, multiple regions can map to the same sequence segment. If a protein is annotated multiple times with the
same type of experiment it is counted once. The number of residues is the sum of region lengths.
Figure 2. Distribution of disorder segment lengths. Segment lengths are binned in groups of 10 residues, e.g. the column 10 showing lengths between 10
and 19 residues. The current DisProt release is distinguished by experimental technique (X-ray in green, NMR in blue and other methods in red). The
previous DisProt release is shown in a single gray bar as it did not have the experimental technique in a machine-readable format.
or isoform assignments, wrong IDR positioning, untracked
disorder evidence (e.g. missing explicit literature reference)
and weak evidence (e.g. based on very short fragments,
please note that theminimal length of an IDR inDisProt 7.0
is 5 residues). Moreover, disorder annotations based on not
traceable author/curator statements were discarded.Where
necessary, a curator comment now highlights criticisms rel-
ative to a given evidence/experiment, e.g. if the experiment
has been carried out on an engineered protein. Regions
annotated as structured in previous DisProt releases were
removed (33 regions). Information related to experiments
has been simplified by skipping technical details regarding
experimental conditions. However, weak experimental evi-
dence is filtered out by the curator during annotation and
tagged with one of three ambiguous labels. Overall, DisProt
7.0 includes 804 entries and 2167 disordered regions, with
a total of 92 432 amino acids with clear experimental and
functional annotations (Table 1), and the length distribu-
tion of disordered regions has significantly changed from
the last release of DisProt (Figure 2).
New feature: functional classification
IDPs/IDRs carry out important functions in the cell. The
field has settled on the notion that structural disorder rep-
resents a continuum of states from fully folded to fully un-
folded (random coil-like), and function may come from
any of the states and transitions between them. That is,
their function may come directly from the disordered state
or from molecular recognition and binding to partner
molecule(s). We derive our classification from the logic of
the gene ontology classification scheme (35), which is based
on three structured ontologies ascribing functional terms to
gene products (proteins) in terms of their associated biolog-
ical processes (BP), cellular components (CC) and molecu-
lar functions (MF). Apparently, the CC and BP ontologies
do not depend on the disordered status of the protein, they
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Table 2. Major functional categories of the MFUN ontology of DisProt
MFUN code Generic functional category Functional category
MFUN 01 Entropic chain Flexible linker/spacer
Entropic bristle
Entropic clock
Entropic spring
Structural mortar
Self-transport through channel
MFUN 02 Molecular recognition: assembler Assembler
Localization (targeting)
Localization (tethering)
Prion (self-assembly, polymerization)
Liquid-liquid phase separation/demixing (self-assembly)
MFUN 03 Molecular recognition: scavenger Neutralization of toxic molecules
Metal binding/metal sponge
Water storage
MFUN 04 Molecular recognition: effector Inhibitor
Disassembler
Activator
cis-regulatory elements (inhibitory modules)
DNA bending
DNA unwinding
MFUN 05 Molecular recognition: display site Phosphorylation
Acetylation
Methylation
Glycosylation
Ubiquitination
Fatty acylation (myristolation and palmitoylation)
Limited proteolysis
MFUN 06 Molecular recognition: chaperone Protein detergent/solvate layer
Space filling
Entropic exclusion
Entropy transfer
The functional schemes are an open hierarchy. One goal of sharing information with the community throughDisProt is to refine our views of the functional
modes of IDPs.
simply reflect the intracellular location of the protein and
the BP it participates in, which can be kept without refer-
ence for the disordered status (35). The situation is entirely
different with MF, which describes the elemental activities
of a protein at the molecular level. In this regard, IDPs basi-
cally differ from folded proteins, such as enzymes or ligand-
binding receptors, because their mode of action and type
of function are usually completely different from those of
folded proteins. Therefore, we have developed a novel classi-
fication scheme that merges and expands previous schemes
that suggested thirty (36) and six (9) different categories, to
provide classified descriptors for their MFs. Because pre-
vious categories (9,36) lacked coherence (for example, they
treated structural transitions and interaction partners at the
same level), we created a rational scheme that distinguishes
these different types of ontologies (cf. Table 2 and ref. (3)).
The three sub-ontologies are as follows: (i) molecular
function of disorder (MFUN): describes the type of func-
tional readout of function (such as molecular chaperone);
(ii) molecular transition (TRAN) necessary for function
(such as disorder-to-order transition); and (iii) molecular
partner (PART) that is recognized by the disordered protein
(such as protein/RNA/DNA/smallmolecule). TheMFUN
ontology is described in detail in Table 1. The TRAN on-
tology can be further simplified to two IDR states (disorder
and transition) to highlight different types of behavior, e.g.
in the feature viewer of each DisProt entry.
CONCLUSIONS AND FUTURE WORK
We have presented an updated and completely re-worked
version of the DisProt database. It now features state-of-
the-art database and web technology, enabling program-
matic access of interested parties. The content was ex-
panded by defining a standardized set of experimental tech-
niques and a novel functional ontology of disordered seg-
ments. Both allow for a richer description of disorder which
may be used for further analyses. The other main improve-
ment in DisProt is a complete re-annotation of existing en-
tries to remove inconsistencies and an expansion of ca. 50%
over the previous release, which also resulted in a signifi-
cant shift in the length coverage of disordered regions in the
database. This advance was made possible by a distributed
annotation effort coordinated by the COST Action NGP-
net (URL: ngp-net.bio.unipd.it) involving a dozen different
groups and close to 40 annotators. The longer term main-
tenance of DisProt is provided by the Italian node of the
European bioinformatics infrastructure Elixir. In the future
we hope that DisProt can be able to provide disorder anno-
tations for UniProt.
Finally, we hope that the upgrade of DisProt will encour-
age the scientific community to deposit experimental evi-
dence for disorder within this unique repository, and that
this renewedmomentumwill lead to an increased awareness
of the importance of intrinsic disorder in proteins.
D226 Nucleic Acids Research, 2017, Vol. 45, Database issue
FUNDING
COST Action BM1405 NGP-net; ELIXIR-IIB (elixir-
italy.org); ‘Lendu¨let’ Grant from the Hungarian Academy
of Sciences [LP2014-16 to Z.D.]; Hungarian Scientific Re-
search Fund [OTKA K 108798 to Z.D.]; AIRC Research
Fellowship (to D.P.); SpanishMinisterio de Educacio´n Cul-
tura i Deporte PhD Fellowship (to J.P.); Mexican Na-
tional Council for Science and Technology (CONACYT)
PhD Fellowship [215503 to M.M.-C.]; Grant PortoNeu-
roDRIve@i3S funded by Norte Portugal Regional Opera-
tional Programme (NORTE 2020), under the PORTUGAL
2020 Partnership Agreement, through the European Re-
gional Development Fund (ERDF) (to S.M.-R.); Direction
Ge´ne´rale des Arme´es and Aix-Marseille University PhD
Fellowship (to E.Sa.); OTKAGrant [PD-OTKA 108772 to
E.Sc.]; French Ministry of National Education, Research
and Technology PhD Fellowship (to A.S.); Ministry of Ed-
ucation, Science and Technological Development of the Re-
public of Serbia [173001, 173049 to N.V., R.D.]; ICREA-
Academia Award (to S.V.); Odysseus Grant from Research
Foundation Flanders (FWO) [G.0029.12 to P.T.]; AIRC IG
Grant [17753 to S.T., in part]; Italian Ministry of Health
[GR-2011-02347754 to E.L., S.T.; GR-2011-02346845 to
S.T.]; Swedish Research Council Grant [VR-NT 2012-5046
to A.E.]. Computational resources were provided by the
Swedish National Infrastructure for Computing (SNIC)
at NSC. Funding for open access charge: COST Action
BM1405 NGP-net.
Conflict of interest statement.None declared.
REFERENCES
1. Berman,H.M., Westbrook,J., Feng,Z., Gilliland,G., Bhat,T.N.,
Weissig,H., Shindyalov,I.N. and Bourne,P.E. (2000) The protein data
bank. Nucleic Acids Res., 28, 235–242.
2. Oldfield,C.J. and Dunker,A.K. (2014) Intrinsically disordered
proteins and intrinsically disordered protein regions. Annu. Rev.
Biochem., 83, 553–584.
3. van der Lee,R., Buljan,M., Lang,B., Weatheritt,R.J.,
Daughdrill,G.W., Dunker,A.K., Fuxreiter,M., Gough,J., Gsponer,J.,
Jones,D.T. et al. (2014) Classification of intrinsically disordered
regions and proteins. Chem. Rev., 114, 6589–6631.
4. Habchi,J., Tompa,P., Longhi,S. and Uversky,V.N. (2014) Introducing
protein intrinsic disorder. Chem. Rev., 114, 6561–6588.
5. Xie,H., Vucetic,S., Iakoucheva,L.M., Oldfield,C.J., Dunker,A.K.,
Uversky,V.N. and Obradovic,Z. (2007) Functional anthology of
intrinsic disorder. 1. Biological processes and functions of proteins
with long disordered regions. J. Proteome Res., 6, 1882–1898.
6. Uversky,V.N., Oldfield,C.J. and Dunker,A.K. (2008) Intrinsically
disordered proteins in human diseases: introducing the D2 concept.
Annu. Rev. Biophys., 37, 215–246.
7. Metallo,S.J. (2010) Intrinsically disordered proteins are potential
drug targets. Curr. Opin. Chem. Biol., 14, 481–488.
8. Varadi,M., Kosol,S., Lebrun,P., Valentini,E., Blackledge,M.,
Dunker,A.K., Felli,I.C., Forman-Kay,J.D., Kriwacki,R.W.,
Pierattelli,R. et al. (2014) pE-DB: a database of structural ensembles
of intrinsically disordered and of unfolded proteins. Nucleic Acids
Res., 42, D326–D335.
9. Tompa,P. (2005) The interplay between structure and function in
intrinsically unstructured proteins. FEBS Lett., 579, 3346–3354.
10. Wright,P.E. and Dyson,H.J. (2009) Linking folding and binding.
Curr. Opin. Struct. Biol., 19, 31–38.
11. Iakoucheva,L.M., Radivojac,P., Brown,C.J., O’Connor,T.R.,
Sikes,J.G., Obradovic,Z. and Dunker,A.K. (2004) The importance of
intrinsic disorder for protein phosphorylation. Nucleic Acids Res., 32,
1037–1049.
12. Tompa,P. (2014) Multisteric regulation by structural disorder in
modular signaling proteins: an extension of the concept of allostery.
Chem. Rev., 114, 6715–6732.
13. Vucetic,S., Obradovic,Z., Vacic,V., Radivojac,P., Peng,K.,
Iakoucheva,L.M., Cortese,M.S., Lawson,J.D., Brown,C.J., Sikes,J.G.
et al. (2005) DisProt: a database of protein disorder. Bioinformatics,
21, 137–140.
14. Sickmeier,M., Hamilton,J.A., LeGall,T., Vacic,V., Cortese,M.S.,
Tantos,A., Szabo,B., Tompa,P., Chen,J., Uversky,V.N. et al. (2007)
DisProt: the Database of Disordered Proteins. Nucleic Acids Res., 35,
D786–D793.
15. Oates,M.E., Romero,P., Ishida,T., Ghalwash,M., Mizianty,M.J.,
Xue,B., Dosztanyi,Z., Uversky,V.N., Obradovic,Z., Kurgan,L. et al.
(2013) D(2)P(2): database of disordered protein predictions. Nucleic
Acids Res., 41, D508–D516.
16. Potenza,E., Di Domenico,T., Walsh,I. and Tosatto,S.C. (2015)
MobiDB 2.0: an improved database of intrinsically disordered and
mobile proteins. Nucleic Acids Res., 43, D315–D320.
17. Fukuchi,S., Sakamoto,S., Nobe,Y., Murakami,S.D., Amemiya,T.,
Hosoda,K., Koike,R., Hiroaki,H. and Ota,M. (2012) IDEAL:
intrinsically disordered proteins with extensive annotations and
literature. Nucleic Acids Res., 40, D507–D511.
18. Mohan,A., Oldfield,C.J., Radivojac,P., Vacic,V., Cortese,M.S.,
Dunker,A.K. and Uversky,V.N. (2006) Analysis of molecular
recognition features (MoRFs). J. Mol. Biol., 362, 1043–1059.
19. Dinkel,H., Van Roey,K., Michael,S., Kumar,M., Uyar,B.,
Altenberg,B., Milchevskaya,V., Schneider,M., Kuhn,H., Behrendt,A.
et al. (2016) ELM 2016–data update and new functionality of the
eukaryotic linear motif resource. Nucleic Acids Res., 44, D294–D300.
20. Tompa,P., Fuxreiter,M., Oldfield,C.J., Simon,I., Dunker,A.K. and
Uversky,V.N. (2009) Close encounters of the third kind: disordered
domains and the interactions of proteins. Bioessays, 31, 328–335.
21. Finn,R.D., Coggill,P., Eberhardt,R.Y., Eddy,S.R., Mistry,J.,
Mitchell,A.L., Potter,S.C., Punta,M., Qureshi,M.,
Sangrador-Vegas,A. et al. (2016) The Pfam protein families database:
towards a more sustainable future. Nucleic Acids Res., 44,
D279–D285.
22. Receveur-Brechot,V., Bourhis,J.M., Uversky,V.N., Canard,B. and
Longhi,S. (2006) Assessing protein disorder and induced folding.
Proteins, 62, 24–45.
23. Kosol,S., Contreras-Martos,S., Cedeno,C. and Tompa,P. (2013)
Structural characterization of intrinsically disordered proteins by
NMR spectroscopy.Molecules, 18, 10802–10828.
24. Felli,I.C. and Pierattelli,R. (2012) Recent progress in NMR
spectroscopy: toward the study of intrinsically disordered proteins of
increasing size and complexity. IUBMB Life, 64, 473–481.
25. Theillet,F.X., Binolfi,A., Bekei,B., Martorana,A., Rose,H.M.,
Stuiver,M., Verzini,S., Lorenz,D., van Rossum,M., Goldfarb,D. et al.
(2016) Structural disorder of monomeric alpha-synuclein persists in
mammalian cells. Nature, 530, 45–50.
26. Schuler,B., Soranno,A., Hofmann,H. and Nettels,D. (2016)
Single-molecule FRET spectroscopy and the polymer physics of
unfolded and intrinsically disordered Proteins. Annu. Rev. Biophys.,
45, 207–231.
27. Kaltashov,I.A., Bobst,C.E. and Abzalimov,R.R. (2013) Mass
spectrometry-based methods to study protein architecture and
dynamics. Protein Sci., 22, 530–544.
28. Borysik,A.J., Kovacs,D., Guharoy,M. and Tompa,P. (2015) Ensemble
methods enable a new definition for the solution to gas-phase transfer
of intrinsically disordered proteins. J. Am. Chem. Soc., 137,
13807–13817.
29. Miyagi,A., Tsunaka,Y., Uchihashi,T., Mayanagi,K., Hirose,S.,
Morikawa,K. and Ando,T. (2008) Visualization of intrinsically
disordered regions of proteins by high-speed atomic force
microscopy. Chemphyschem, 9, 1859–1866.
30. Jakob,U., Kriwacki,R. and Uversky,V.N. (2014) Conditionally and
transiently disordered proteins: awakening cryptic disorder to
regulate protein function. Chem. Rev., 114, 6779–6805.
31. DeForte,S. and Uversky,V.N. (2016) Resolving the ambiguity:
making sense of intrinsic disorder when PDB structures disagree.
Protein Sci., 25, 676–688.
32. Blocquel,D., Habchi,J., Durand,E., Sevajol,M., Ferron,F., Erales,J.,
Papageorgiou,N. and Longhi,S. (2014) Coiled-coil deformations in
crystal structures: the measles virus phosphoprotein multimerization
Nucleic Acids Research, 2017, Vol. 45, Database issue D227
domain as an illustrative example. Acta Crystallogr. D Biol.
Crystallogr., 70, 1589–1603.
33. Sterckx,Y.G., Volkov,A.N., Vranken,W.F., Kragelj,J., Jensen,M.R.,
Buts,L., Garcia-Pino,A., Jove,T., Van Melderen,L., Blackledge,M.
et al. (2014) Small-angle X-ray scattering- and nuclear magnetic
resonance-derived conformational ensemble of the highly flexible
antitoxin PaaA2. Structure, 22, 854–865.
34. Aznauryan,M., Delgado,L., Soranno,A., Nettels,D., Huang,J.R.,
Labhardt,A.M., Grzesiek,S. and Schuler,B. (2016) Comprehensive
structural and dynamical view of an unfolded protein from the
combination of single-molecule FRET, NMR, and SAXS. Proc. Natl.
Acad. Sci. U.S.A., 113, E5389–E5398.
35. Consortium, G.O. (2015) Gene ontology consortium: going
forward. Nucleic Acids Res., 43, D1049–D1056.
36. Dunker,A.K., Brown,C.J., Lawson,J.D., Iakoucheva,L.M. and
Obradovic,Z. (2002) Intrinsic disorder and protein function.
Biochemistry, 41, 6573–6582.
